Release your full potential
Be active. Be free. Experience real-life
superior treatment with PADTM Technology based drugs.
MC2 Therapeutics is a privately held emerging dermatology and eye care pharmaceutical company. Read more about MC2 Therapeutics.
Our PAD™ Technology is a new class of vehicle that enables development of new topical drugs with superior real-life performance. Read more about our platform.
Our current pipeline includes programs in major chronic topical diseases such as psoriasis, atopic dermatitis, pruritus and dry and sensitive skin and eyes. Read more about our pipeline.
READ FULL ARTICLE
Copenhagen, August, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company, has ...
Copenhagen, February 24th, 2017 – MC2 Therapeutics today announced that two abstracts were accepted for ...
MC2 Biotek, a clinical stage emerging specialty pharmaceutical company focusing on dermatology and ophthalmology, today ...